Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2001-07-31 Earnings Release
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Fresenius AG
Earnings Release Classification · 100% confidence The document is an 'Ad-hoc-Mitteilung' (Ad-hoc announcement) dated July 31, 2001, reporting key financial figures for the '1. Halbjahr 2001' (First Half Year 2001). It explicitly states revenue, EBIT, and net income figures for the period, which is characteristic of an initial release of periodic financial results. This aligns perfectly with the definition of an Earnings Release (ER), which covers key highlights of quarterly/periodical results. Although it covers a half-year period (which might suggest an Interim Report (IR)), the format is a brief, high-level announcement typical of an ER rather than a comprehensive report. H1 2001
2001-07-31 German
Ad hoc-Service: Fresenius AG
Earnings Release Classification · 100% confidence The document is explicitly titled 'Ad hoc-Mitteilung' (Ad hoc announcement) and is dated May 3, 2001. It provides key financial highlights for the '1. Quartal 2001' (First Quarter 2001), including revenue, EBIT, net income, and earnings per share, comparing them to the previous year's first quarter. This structure—a brief announcement of key period results—perfectly matches the definition of an Earnings Release (ER). It is not a full report (10-K or IR) nor a transcript (CT). Q1 2001
2001-05-03 German
Ad hoc-Service: Fresenius AG
Share Issue/Capital Change Classification · 98% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) dated March 13, 2001, from Fresenius AG. The core content explicitly states that the Management Board and Supervisory Board have decided to propose a capital increase from company funds through the issuance of new shares (Gratisaktien) in a 1:1 ratio, increasing the share capital from EUR 51.2 million to EUR 102.4 million. This action directly relates to changes in the company's capital structure through the issuance of new shares. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV), but a specific announcement about a capital structure change.
2001-03-13 German
Ad hoc-Service: Fresenius AG
Earnings Release Classification · 99% confidence The document is an 'Ad hoc-Mitteilung' (Ad hoc announcement) dated March 6, 2001, reporting the successful conclusion of the 2000 fiscal year for Fresenius AG. It explicitly states key financial results (Revenue, EBIT, Net Income) for the year 2000 and announces a proposed dividend increase and a special dividend. This content—the initial release of key financial highlights for a period—perfectly matches the definition of an Earnings Release (ER). It is not a full Annual Report (10-K), nor is it a transcript (CT) or a general regulatory filing (RNS) since it fits a more specific category. FY 2000
2001-03-06 German
Ad hoc-Service: Fresenius AG
M&A Activity Classification · 98% confidence The document is an 'Ad hoc-Service' announcement dated December 19, 2000, detailing Fresenius AG's submission of a takeover offer (Übernahme-Angebot) to the shareholders of Wittgensteiner Kliniken AG. The core subject is the acquisition of one company by another, involving an exchange of shares and a defined acceptance period. This clearly falls under the category of Merger & Acquisition (M&A) activity. The corresponding code is TAR (M&A Activity). The document length is relatively short (3042 chars), but it is the primary announcement of the transaction itself, not just an announcement that a report is forthcoming, thus TAR is more specific than RPA or RNS.
2000-12-19 German
Ad hoc-Service: Fresenius AG
Earnings Release Classification · 100% confidence The document is an 'Ad hoc-Service' announcement dated October 31, 2000, detailing key financial performance metrics (Umsatz/Revenue, EBIT, Konzern-Ergebnis/Net Income) for the first three quarters (1.-3. Quartal 2000) of the year. This format, providing preliminary or summary financial highlights immediately following the period close, aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). It is too brief and summary-focused to be a full Interim Report (IR) or Annual Report (10-K). 9M 2000
2000-10-31 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.